» Articles » PMID: 6368234

The Use of 123I-labeled Heptadecanoic Acid (HDA) As Metabolic Tracer: Preliminary Report

Overview
Journal Eur J Nucl Med
Specialty Nuclear Medicine
Date 1984 Jan 1
PMID 6368234
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The feasibility of using 123I-heptadecanoic acid (HDA) as a metabolic tracer was studied. Different administration routes of HDA were compared. An intracoronary bolus injection was given to calves (n = 3), and an intravenous injection was given to patients (n = 4). In addition, we examined the influence of 4-h halothane anesthesia in calves and in patients the impact of an insulin (1.5 IU/kg) + glucose (1.5 g/kg) infusion on the myocardial kinetics of HDA. Data were accumulated with a scintillation probe in calves (t = 50 min) and a gamma camera in patients (t = 70 min). In calves after an intracoronary bolus injection of HDA the myocardial time-activity curve could be described by two exponentials. The mean elimination half-time of the initial phase (ta 1/2) was 7.3 min and that of the second phase (tb 1/2) was 35 min. The ratio of the size of the initial and second component at to was 0.93. Halothane anesthesia prolonged the elimination half-times and reduced the component ratio. The biphasic behavior of the myocardial time-activity curve was maintained in patients after intravenous administration of HDA under basal conditions (initial ta 1/2 = 8.4 min). However, during infusion of insulin + glucose the decline in the myocardial activity was prolonged and monoexponential. This data shows that insulin glucose, interfering with fatty acid metabolism, influences the myocardial washout of HDA, and thus support its use as a metabolic tracer.

Citing Articles

Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT.

Tamaki N, Fujibayashi Y, Magata Y, Yonekura Y, Konishi J J Nucl Cardiol. 1995; 2(3):256-66.

PMID: 9420796 DOI: 10.1016/s1071-3581(05)80063-7.


The use of iodinated free fatty acids for assessing fatty acid metabolism.

Tamaki N, Kawamoto M J Nucl Cardiol. 1994; 1(2 Pt 2):S72-8.

PMID: 9420701 DOI: 10.1007/BF02940072.


Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives.

Knapp Jr F, Kropp J Eur J Nucl Med. 1995; 22(4):361-81.

PMID: 7607269 DOI: 10.1007/BF00941855.


Do iodinated fatty acids undergo a nonspecific deiodination in the myocardium?.

Cuchet P, Demaison L, Bontemps L, Keriel C, MATHIEU J, Pernin C Eur J Nucl Med. 1985; 10(11-12):505-10.

PMID: 4029208 DOI: 10.1007/BF00252742.


Sequential sampling: a new acquisition technique for fatty acid kinetics from quasi-simultaneous multiple projections.

Herzog H, Spohr G, Notohamiprodjo G, Feinendegen L Eur J Nucl Med. 1986; 12(5-6):263-6.

PMID: 3490981 DOI: 10.1007/BF00251983.


References
1.
Neely J, Rovetto M, Oram J . Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972; 15(3):289-329. DOI: 10.1016/0033-0620(72)90029-1. View

2.
Lerch R, Ambos H, Bergmann S, Welch M, Ter-Pogossian M, Sobel B . Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate. Circulation. 1981; 64(4):689-99. DOI: 10.1161/01.cir.64.4.689. View

3.
Evans J, Gunton R, Baker R, BEANLANDS D, SPEARS J . USE OF RADIOIODINATED FATTY ACID FOR PHOTOSCANS OF THE HEART. Circ Res. 1965; 16:1-10. DOI: 10.1161/01.res.16.1.1. View

4.
Schon H, Schelbert H, Robinson G, Najafi A, Huang S, Hansen H . C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. Am Heart J. 1982; 103(4 Pt 1):532-47. DOI: 10.1016/0002-8703(82)90341-6. View

5.
POE N, Robinson Jr G, Zielinski F, Cabeen Jr W, Smith J, Gomes A . Myocardial imaging with 123I-hexadecenoic acid. Radiology. 1977; 124(2):419-24. DOI: 10.1148/124.2.419. View